Fact CheckerSign in

NCT07720102Enrolling by invitation

Patient Reported Outcomes Following Percutaneous Lung Ablation

Source: ClinicalTrials.gov · Last updated 29 Oct 2026

Brief summary (registry, in English)

This study evaluates satisfaction with percutaneous ablation and any symptoms experienced before and after the procedure in patients with lung tumors.

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
50 (estimated)
First submitted
17 Jul 2026
Start date
13 Aug 2026
Primary completion date
31 Jul 2028
Lead sponsor
Mayo Clinic
Diseases
Lung cancer
NCT number
NCT07720102

What you commit to

  • Study type: Observational
  • Planned participants: 50
  • From 13 Aug 2026 to the primary completion date, 31 Jul 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Decline to participate in research

Who the study is looking for

  • Undergoing percutaneous lung ablation

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Mayo Clinic in Rochester
Coordinator of this site? Confirm its status
RochesterUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.